Eli Lilly wants to incentivize more employers to cover GLP-1s
Lilly will offer Zepbound, an injectable GLP-1 medication, at a price of $449 per month through a platform called Lilly Connect.
Lilly will offer Zepbound, an injectable GLP-1 medication, at a price of $449 per month through a platform called Lilly Connect.
The CHRO of Pella Corporation said he hopes a near-site wellness center will spur cost savings for workers and the business.
President Donald Trump promised Americans they’ll “save a fortune” by buying drugs through TrumpRx, but it’s not clear workers with insurance will see meaningful savings.
Nearly three-quarters said they were moderately, very, or extremely concerned about pharmacy costs being “unsustainable,” despite legislative efforts to temper them.
A recent Aon analysis found medical and pharmacy claim costs grew more slowly for GLP-1 users compared to non-users in the years after patients started the medication.
When insurance plans and healthcare providers spar over costs, workers may find themselves in the crosshairs—and suddenly without coverage.
Updated guidelines from the Department of Health and Human Services may inform how HR teams think about cancer prevention strategy going forward.
From recruiting and retention to company culture and the latest in HR tech, HR Brew delivers up-to-date industry news and tips to help HR pros stay nimble in today’s fast-changing business environment.
By subscribing, you accept our Terms & Privacy Policy.